Dr. Reddy’s Laboratories to acquire Mayne Pharma’s US retail generics portfolio
Dr. Reddy's Laboratories has agreed to acquire the US generic prescription product portfolio of Mayne Pharma Group, an Australian pharma company, in a deal worth ... Read More
Dr. Reddy’s Labs, Slayback sign licensing deal for Brimonidine Tartrate
Dr. Reddy’s Laboratories said that it has signed a licensing deal with New Jersey-based Slayback Pharma for acquiring rights in the latter’s Brimonidine Tartrate Ophthalmic ... Read More
Dr. Reddy’s Laboratories relaunches OTC Naproxen Sodium Tablets in US
Dr. Reddy’s Laboratories said that it has relaunched over-the-counter (OTC) Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Bayer HealthCare’s Aleve, in the ... Read More
Dr. Reddy’s launches Sputnik V Covid vaccine in India at Rs 995 per dose
Dr. Reddy's Laboratories has launched the Sputnik V Covid vaccine in India with the first dose of the Russian vaccine administered today in Hyderabad. The ... Read More
Appili Therapeutics begins Phase 3 clinical trial for Avigan in fight against Covid-19
Appili Therapeutics, a Canadian infectious disease biopharmaceutical company, has announced a major milestone in its fight against Covid-19: the commencement of the Phase 3 clinical ... Read More